Illumina (ILMN) Announces Preliminary Q4 Sales, Issues ’22 View

Illumina, Inc. ILMN recently announced preliminary fourth-quarter and full-year 2021 revenues along with 2022 top-line guidance at the 2022 J.P. Morgan Healthcare Conference. The company also discussed its latest partnerships and product pipelines, defining its long-term growth opportunities. – Zacks Preliminary Q4 & ’21 ResultsIllumina reported preliminary consolidated fourth-quarter revenues of around $1.19 billion, up…

Send this to a friend